Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

(Abstracted from N Engl J Med 2020;382:1906–1915) Worldwide, 15% to 50% of women of reproductive age have bacterial vaginosis (BV) and are treated with an antibiotic agent. Within 3 months after treatment, the infection recurs in 20% to 75% of women.